American scientists proved that the extracts of marijuana effectively oppress the symptoms of multiple sclerosis and, as a result, can be used for the treatment of this desease, the Psych Org reports.
Meta-analysis of randomized placebo-controlled researches by the scientists from Los Angeles Global Neuroscience Initiative Foundation (GNIF) showed that five from six researches testify to the lowering of spasticity and increase in range of motions among the patient suffering from MS if they take the extracts of redroot (Cannabis sativa).
Active substances of the extracts were elta9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
Spasticity - an involuntary increase in muscle tone or rapid muscle contractions – is one of the more common and distressing symptoms of MS. The existing methods of spasticity reducing are difficult to obtain, cause serious side effects, and ineffective.
Meta-analysis has shown that the quantity of appearance of side effects due to marijuana extracts taking connected with cannabinoids affect psychic widely varies depending on the dosage. But according to the results of the studies, similar effects were observed during placebo taking.
One of the authors of the research, Shaheen Lakhan, commented on the received data the following way: “The therapeutic potential of cannabinoids in MS appears to be comprehensive, and should be given considerable attention”.
The results of the study are published in the scientific magazine “BMC Neurology”.
